Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |